Search
Displaying 281–290 of 543 for “Retinitis pigmentosa”
-
Partner News
Acquisition significantly expands Janssen’s eye disease portfolio and strengthens its gene therapy capabilities. Late-stage AMD affects millions of people with no effective treatments currently available .
-
AGTC Announces Results for Achromatopsia Gene Therapy Clinical Trials
Research NewsThe company will continue enrolling younger patients in higher dosing groups.
-
Positivity Always Shines Through
Beacon StoriesLinda has been blind since birth, but she never lets her visual impairments stop her from doing what she loves and staying positive through it all.
-
SparingVision Raises €44.5 Million for Gene-Independent RP Therapy
Research NewsThe company is planning a clinical trial for its emerging neuroprotective treatment in 2021
-
RP Treatment Derived from Induced Pluripotent Stem Cells Advances into Clinical Trial
Research NewsThe stem cells were derived from mature blood cells and coaxed to become photoreceptors
-
Foundation Fighting Blindness to Host Fall National Virtual VisionWalk
Foundation NewsThe Virtual VisionWalk on October 24th will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
The Dutterers Aren't Afraid to Share Their Story
Beacon StoriesSteve and Dot Dutterer have kind and approachable personalities that captivate everyone they meet. With their expansive network, and a lot of hard work and dedication over the past 19 years, Steve and Dot have raised more than $743,000 for the Foundation through the Baltimore VisionWalk.
-
My Retina Tracker Program and Registry Featured in American Journal of Medical Genetics
Research NewsThe paper provides insights into the genetic landscape of inherited retinal diseases
-
4D Molecular Therapeutics Launches Phase 1 Clinical Trial for Choroideremia Gene Therapy
Research NewsGene therapy delivered by intravitreal injection
-
jCyte Reports Promising Results for Phase 2b Clinical Trial of its Cellular Therapy for RP
Research NewsThe emerging therapy is designed to work independent of the mutated gene causing vision loss
